Journal of Affective Disorders
Volume 75, Issue 1 , Pages 59-64 , June 2003

Glia as a putative target for antidepressant treatments

Received 3 October 2001 ,Accepted 27 December 2001.

References 

  1. Ahlemeyer B, Beier H, Semkova I, Schaper C, Krieglstein J. S100β protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5-HT1A-receptor agonist, Bay X3702. Brain Res. 2000;858:121–128
  2. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 2001;55:585–595
  3. Dave V, Kimelberg HK. Na+-Dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex. J. Neurosci. 1994;14:4972–4986
  4. Deecher DC, Wilcox BD, Dave V, Rossman PA, Kimelberg HK. Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures. J. Neurosci. Res. 1993;35:246–256
  5. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–716
  6. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001;33:637–668
  7. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology. 1999;21:46S–51S
  8. Haring JH, Hagan A, Olson J, Rodgers B. Hippocampal serotonin levels influence the expression of S100β detected by immunocytochemistry. Brain Res. 1993;631:119–123
  9. Healy D. The Antidepressant Era. Cambridge, UK: Harvard University Press; 1999;
  10. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 1995;270:25752–25761
  11. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000;275:40096–40105
  12. Inazu M, Takeda H, Ikoshi H, Sugisawa M, Uchida Y, Matsumiya T. Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem. Int. 2001;39:39–49
  13. Kubota N, Kiuchi Y, Nemoto M, Oyamada H, Ohno M, Funahashi H, et al. Regulation of serotonin transporter gene expression in human glial cells by growth factors. Eur. J. Pharmacol. 2001;417:69–76
  14. Laming PR, Kimelberg H, Robinson S, Salm A, Hawrylak N, Muller C, et al. Neuronal-glia interactions and behaviour. Neurosci. Biobehav. Rev. 2000;24:295–340
  15. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000;20:9104–9110
  16. Manev H, Uz T, Smalheiser NR, Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 2001;411:67–70
  17. Manev R, Uz T, Manev H. Fluoxetine increases the content of neurotrophic protein S100β in the rat hippocampus. Eur. J. Pharmacol. 2001;420:R1–R2
  18. Millward TA, Heizmann CW, Schafer BW, Hemmings BA. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 1998;17:5913–5922
  19. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996;16:2365–2372
  20. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic Press; 1996;
  21. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatr. 2000;48:766–777
  22. Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease. Brain Res. 2001;888:256–262
  23. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta. 2000;1498:99–111
  24. Scotto C, Mely Y, Ohshima H, Garin J, Chambaz E, Baudier J. Cysteine oxidation in the mitogenic S100β protein leads to changes in phosphorylation by catalytic CKII-α subunit. J. Biol. Chem. 1998;273:3901–3908
  25. Selinfreund RH, et al.  Neurotrophic protein S100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA. 1991;88:3554–3558
  26. Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J. Neurosci. 2001;21:7153–7160
  27. Snyder JS, Kee N, Wojtowicz JM. Effects of adult neurogenesis on synaptic plasticity in the rat dentate gyrus. J. Neurophysiol. 2001;85:2423–2431
  28. Van Eldik LJ, Griffin WS. S100 beta expression in Alzheimer’s disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1994;1223:398–403
  29. Whitaker-Azmitia PM, Murphy R, Azmitia EC. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 1990;24:155–158
  30. Wong M-L, Licinio J. Research and treatment approaches to depression. Nat. Rev. Neurosci. 2001;2:343–351

PII: S0165-0327(02)00044-7

doi: 10.1016/S0165-0327(02)00044-7

Journal of Affective Disorders
Volume 75, Issue 1 , Pages 59-64 , June 2003